Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial

Introduction Personalised cancer screening aims to improve benefits, reduce harms and being more cost-effective than age-based screening. The objective of the DECIDO study is to assess the acceptability and feasibility of offering risk-based personalised breast cancer screening and its integration i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Hernandez, Anna Pons-Rodriguez, Carles Forné Izquierdo, Jordi Vilaplana-Mayoral, Inés Cruz-Esteve, Isabel Sánchez-López, Mercè Reñé-Reñé, Cristina Cazorla, Marta Hernández-Andreu, Gisela Galindo-Ortego, Montserrat Llorens Gabandé, Celmira Laza-Vásquez, Pau Balaguer-Llaquet, Montserrat Martínez-Alonso, Montserrat Rué, Iván-David Benítez, Alexandra Bertran, Àngels Cardona, Misericòrdia Carles-Lavila, Cristina Cazorla-Sánchez, Núria Codern, Carles Forné-Izquierdo, Maria José Hernández-Andreu, Edelmir Iglesias, Montserrat Llorens-Gabandé, Maria José Pérez-Lacasta, Hèctor Perpiñán
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2020
Materias:
R
Acceso en línea:https://doaj.org/article/68dc74aca89b461e8bd77f06e4165612
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:68dc74aca89b461e8bd77f06e4165612
record_format dspace
spelling oai:doaj.org-article:68dc74aca89b461e8bd77f06e41656122021-11-20T15:30:04ZFeasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial10.1136/bmjopen-2020-0445972044-6055https://doaj.org/article/68dc74aca89b461e8bd77f06e41656122020-12-01T00:00:00Zhttps://bmjopen.bmj.com/content/10/12/e044597.fullhttps://doaj.org/toc/2044-6055Introduction Personalised cancer screening aims to improve benefits, reduce harms and being more cost-effective than age-based screening. The objective of the DECIDO study is to assess the acceptability and feasibility of offering risk-based personalised breast cancer screening and its integration in regular clinical practice in a National Health System setting.Methods and analysis The study is designed as a single-arm proof-of-concept trial. The study sample will include 385 women aged 40–50 years resident in a primary care health area in Spain. The study intervention consists of (1) a baseline visit; (2) breast cancer risk estimation; (3) a second visit for risk communication and screening recommendations based on breast cancer risk and (4) a follow-up to obtain the study outcomes.A polygenic risk score (PRS) will be constructed as a composite likelihood ratio of 83 single nucleotide polymorphisms. The Breast Cancer Surveillance Consortium risk model, including age, race/ethnicity, family history of breast cancer, benign breast disease and breast density will be used to estimate a preliminary 5-year absolute risk of breast cancer. A Bayesian approach will be used to update this risk with the PRS value.The primary outcome measures will be attitude towards, intention to participate in and satisfaction with personalised breast cancer screening. Secondary outcomes will include the proportions of women who accept to participate and who complete the different phases of the study. The exact binomial and the Student’s t-test will be used to obtain 95% CIs.Ethics and dissemination The study protocol was approved by the Drug Research Ethics Committee of the University Hospital Arnau de Vilanova. The trial will be conducted in compliance with this study protocol, the Declaration of Helsinki and Good Clinical Practice.The results will be published in peer-reviewed scientific journals and disseminated in scientific conferences and media.Trial registration number NCT03791008.Marta HernandezAnna Pons-RodriguezCarles Forné IzquierdoJordi Vilaplana-MayoralInés Cruz-EsteveIsabel Sánchez-LópezMercè Reñé-ReñéCristina CazorlaMarta Hernández-AndreuGisela Galindo-OrtegoMontserrat Llorens GabandéCelmira Laza-VásquezPau Balaguer-LlaquetMontserrat Martínez-AlonsoMontserrat RuéIván-David BenítezAlexandra BertranÀngels CardonaMisericòrdia Carles-LavilaCristina Cazorla-SánchezNúria CodernCarles Forné-IzquierdoMaria José Hernández-AndreuEdelmir IglesiasMontserrat Llorens-GabandéMaria José Pérez-LacastaHèctor PerpiñánBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 10, Iss 12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Marta Hernandez
Anna Pons-Rodriguez
Carles Forné Izquierdo
Jordi Vilaplana-Mayoral
Inés Cruz-Esteve
Isabel Sánchez-López
Mercè Reñé-Reñé
Cristina Cazorla
Marta Hernández-Andreu
Gisela Galindo-Ortego
Montserrat Llorens Gabandé
Celmira Laza-Vásquez
Pau Balaguer-Llaquet
Montserrat Martínez-Alonso
Montserrat Rué
Iván-David Benítez
Alexandra Bertran
Àngels Cardona
Misericòrdia Carles-Lavila
Cristina Cazorla-Sánchez
Núria Codern
Carles Forné-Izquierdo
Maria José Hernández-Andreu
Edelmir Iglesias
Montserrat Llorens-Gabandé
Maria José Pérez-Lacasta
Hèctor Perpiñán
Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
description Introduction Personalised cancer screening aims to improve benefits, reduce harms and being more cost-effective than age-based screening. The objective of the DECIDO study is to assess the acceptability and feasibility of offering risk-based personalised breast cancer screening and its integration in regular clinical practice in a National Health System setting.Methods and analysis The study is designed as a single-arm proof-of-concept trial. The study sample will include 385 women aged 40–50 years resident in a primary care health area in Spain. The study intervention consists of (1) a baseline visit; (2) breast cancer risk estimation; (3) a second visit for risk communication and screening recommendations based on breast cancer risk and (4) a follow-up to obtain the study outcomes.A polygenic risk score (PRS) will be constructed as a composite likelihood ratio of 83 single nucleotide polymorphisms. The Breast Cancer Surveillance Consortium risk model, including age, race/ethnicity, family history of breast cancer, benign breast disease and breast density will be used to estimate a preliminary 5-year absolute risk of breast cancer. A Bayesian approach will be used to update this risk with the PRS value.The primary outcome measures will be attitude towards, intention to participate in and satisfaction with personalised breast cancer screening. Secondary outcomes will include the proportions of women who accept to participate and who complete the different phases of the study. The exact binomial and the Student’s t-test will be used to obtain 95% CIs.Ethics and dissemination The study protocol was approved by the Drug Research Ethics Committee of the University Hospital Arnau de Vilanova. The trial will be conducted in compliance with this study protocol, the Declaration of Helsinki and Good Clinical Practice.The results will be published in peer-reviewed scientific journals and disseminated in scientific conferences and media.Trial registration number NCT03791008.
format article
author Marta Hernandez
Anna Pons-Rodriguez
Carles Forné Izquierdo
Jordi Vilaplana-Mayoral
Inés Cruz-Esteve
Isabel Sánchez-López
Mercè Reñé-Reñé
Cristina Cazorla
Marta Hernández-Andreu
Gisela Galindo-Ortego
Montserrat Llorens Gabandé
Celmira Laza-Vásquez
Pau Balaguer-Llaquet
Montserrat Martínez-Alonso
Montserrat Rué
Iván-David Benítez
Alexandra Bertran
Àngels Cardona
Misericòrdia Carles-Lavila
Cristina Cazorla-Sánchez
Núria Codern
Carles Forné-Izquierdo
Maria José Hernández-Andreu
Edelmir Iglesias
Montserrat Llorens-Gabandé
Maria José Pérez-Lacasta
Hèctor Perpiñán
author_facet Marta Hernandez
Anna Pons-Rodriguez
Carles Forné Izquierdo
Jordi Vilaplana-Mayoral
Inés Cruz-Esteve
Isabel Sánchez-López
Mercè Reñé-Reñé
Cristina Cazorla
Marta Hernández-Andreu
Gisela Galindo-Ortego
Montserrat Llorens Gabandé
Celmira Laza-Vásquez
Pau Balaguer-Llaquet
Montserrat Martínez-Alonso
Montserrat Rué
Iván-David Benítez
Alexandra Bertran
Àngels Cardona
Misericòrdia Carles-Lavila
Cristina Cazorla-Sánchez
Núria Codern
Carles Forné-Izquierdo
Maria José Hernández-Andreu
Edelmir Iglesias
Montserrat Llorens-Gabandé
Maria José Pérez-Lacasta
Hèctor Perpiñán
author_sort Marta Hernandez
title Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
title_short Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
title_full Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
title_fullStr Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
title_full_unstemmed Feasibility and acceptability of personalised breast cancer screening (DECIDO study): protocol of a single-arm proof-of-concept trial
title_sort feasibility and acceptability of personalised breast cancer screening (decido study): protocol of a single-arm proof-of-concept trial
publisher BMJ Publishing Group
publishDate 2020
url https://doaj.org/article/68dc74aca89b461e8bd77f06e4165612
work_keys_str_mv AT martahernandez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT annaponsrodriguez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT carlesforneizquierdo feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT jordivilaplanamayoral feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT inescruzesteve feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT isabelsanchezlopez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT mercerenerene feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT cristinacazorla feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT martahernandezandreu feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT giselagalindoortego feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT montserratllorensgabande feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT celmiralazavasquez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT paubalaguerllaquet feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT montserratmartinezalonso feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT montserratrue feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT ivandavidbenitez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT alexandrabertran feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT angelscardona feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT misericordiacarleslavila feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT cristinacazorlasanchez feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT nuriacodern feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT carlesforneizquierdo feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT mariajosehernandezandreu feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT edelmiriglesias feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT montserratllorensgabande feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT mariajoseperezlacasta feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
AT hectorperpinan feasibilityandacceptabilityofpersonalisedbreastcancerscreeningdecidostudyprotocolofasinglearmproofofconcepttrial
_version_ 1718419429335760896